Please contact Jörn Aldag with any inquiries.

News

Date Title
Hookipa Biotech Announces Nature Communications Publication Showing TheraT® Turns Cold Tumors Hot
Hookipa Biotech presents positive data from Phase 1 first-in-human trial of vaccine against cytomegalovirus
Hookipa Biotech announces the appointment of Dr Reinhard Kandera as Chief Financial Officer
Hookipa Biotech announces the appointment of Igor Matushansky, M.D., Ph.D. as Global Head, Research and Development
Hookipa Biotech Announces Publication in Clinical and Vaccine Immunology Highlighting Vaxwave® as an Effective Viral Vector for Vaccination against Congenital Cytomegalovirus Infections
Hookipa Secures EUR 4.16 million Additional Grant Support from the Austrian Research Promotion Agency (FFG) to Develop Arenavirus Vector-Based Cancer Immunotherapies

Events

Date Title

12th Immuno-Oncology Summit

Boston, USA

International Herpesvirus Workshop

Ghent, Belgium

15th Annual Vaccines Research & Development Conference

Baltimore, USA

BioUS

San Diego, USA

ASCO 2017

Chicago, USA

UBS Global Healthcare Conference

New York, USA

BioEquity Europe 2017

Paris, France

2nd Annual Advances in Immuno-Oncology Congress

UK, London

6th International Congenital CMV Conference

Noordwijkerhout, The Netherlands

10th Annual European Life Sciences CEO Forum & Exhibition

Zurich, Switzerland

J.P. Morgan 35th Annual Healthcare Conference

San Francisco, CA, USA